白云山股价微跌0.11% 公司前高管涉医药反腐被立案

金融界
Aug 14

截至2025年8月13日15时,白云山股价报26.78元,较前一交易日下跌0.03元,跌幅0.11%。当日成交量为79641手,成交金额达2.13亿元。

白云山主营业务涵盖中西成药、化学原料药生物医药等研发制造,以及大健康产品、医疗服务等业务领域。公司拥有王老吉、陈李济等知名品牌,在医药行业具有重要地位。

据公开信息显示,白云山及广药集团前董事长李楚源、前董事张春波等高管因涉嫌违法违规被立案调查,涉及问题包括虚增药价套取资金、品牌授权管理腐败等。这是近期医药反腐风暴中的重要案件之一。

资金流向数据显示,8月13日白云山主力资金净流出68.02万元,近五日主力资金累计净流出795.89万元。

风险提示:本文所提及个股及信息仅供参考,不构成任何投资建议。股市有风险,投资需谨慎。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10